Digital Therapeutics: Who May Benefit and What Results Are Realistic

Digital therapeutics are software-based interventions designed to prevent, manage, or treat certain health conditions. They may benefit people who need structured, evidence-based support between visits, but results are usually gradual and work best when combined with professional medical care.

Overview: What digital therapeutics are

Digital therapeutics are software-based interventions that are developed to help prevent, manage, or treat a medical condition. They are often delivered through a smartphone app, tablet, computer program, or connected device. Unlike general wellness apps, digital therapeutics are designed around a defined clinical purpose and are typically supported by evidence showing that they can improve a health outcome for a specific group of patients.

These tools may guide users through structured programs such as cognitive behavioral therapy techniques, medication reminders, symptom tracking, breathing exercises, sleep routines, or coaching for lifestyle change. Some are used on their own for a limited purpose, while others are meant to complement standard medical treatment. In many cases, they help patients practice skills and follow treatment plans between clinic visits.

Digital therapeutics are not all the same. Some are prescription products that require a clinician’s recommendation or oversight, while others are nonprescription tools intended for broader use. What makes them medically important is not simply that they are digital, but that they aim to deliver a measurable therapeutic effect in a safe, structured, and evidence-based way.

Who may benefit from digital therapeutics

Digital therapeutics may benefit people who are motivated to take an active role in their care and who can use a phone, tablet, or computer regularly. They are often most helpful for conditions that respond to repeated practice, self-monitoring, education, or behavior change over time. This includes some long-term conditions where daily habits strongly affect symptoms or disease control.

Examples may include people living with diabetes, high blood pressure, chronic pain, insomnia, anxiety, depression, or respiratory conditions that require regular self-management. They may also be helpful for people trying to improve treatment adherence, track symptoms more accurately, or learn coping strategies in a structured way. In some situations, digital therapeutics are used alongside programs related to diabetes management or support for sleep disorder treatment.

They can also support people who have limited access to frequent in-person care, as long as remote follow-up is appropriate and safe. For some patients, the main benefit is convenience: the ability to engage with therapy at home, practice skills daily, and share progress with a healthcare team. Still, the best candidates are usually those whose needs match the tool’s specific purpose and who have realistic expectations about what software can and cannot do.

Conditions where digital therapeutics may be used

Digital therapeutics are commonly discussed in areas where education, behavior change, and symptom monitoring play a major role. One example is sleep health, where structured programs based on behavioral methods may help some people with insomnia improve sleep habits and reduce unhelpful patterns over time. Similar approaches may be used for stress-related symptoms, mild to moderate anxiety, or depression, especially when guided by a clinician.

Another area is chronic disease management. People with diabetes may use a digital therapeutic to track glucose-related habits, learn problem-solving skills, or strengthen consistency with meals, exercise, and medication routines. In respiratory care, tools may help users record symptoms, follow action plans, or reinforce inhaler technique and trigger awareness. In rehabilitation, software may guide exercises or remind patients how to practice skills at home.

These tools may also support people with pain, digestive symptoms, substance use disorders, or cardiovascular risk factors, depending on the product and the evidence behind it. However, digital therapeutics are not a universal solution. A tool that works well for one condition or one person may not be useful for another, and some symptoms still require direct examination, laboratory testing, imaging, or in-person treatment.

What results are realistic

Realistic results from digital therapeutics are usually meaningful but modest. For many people, the goal is not a sudden cure but better control: fewer symptoms, improved daily function, stronger treatment adherence, better sleep habits, or more confidence in self-management. In chronic conditions, even small changes can matter when they are sustained over time.

Patients may notice progress in areas such as symptom awareness, consistency with medication, healthier routines, or reduced avoidance of helpful behaviors. For example, a person using a sleep-focused digital program may gradually fall asleep more easily or wake less often, while someone using a mental health program may learn coping tools that reduce distress and improve routine functioning. A person with diabetes may become better at recognizing patterns and making informed daily choices.

It is also important to understand that results depend on engagement. Most digital therapeutics work best when used regularly, as directed, and as part of a larger care plan. Benefits may take weeks rather than days, and some users may notice only partial improvement. When symptoms are severe, complex, or rapidly worsening, software support alone is usually not enough and should not delay proper medical evaluation.

• Possible realistic benefits include improved self-management skills
• Better adherence to medical advice or routines
• Reduced symptom burden in selected conditions
• More structured communication with clinicians
• Greater awareness of triggers, patterns, and progress

What affects success

Several factors influence whether digital therapeutics are helpful. One is the match between the patient and the program. A well-designed tool for a clearly defined condition is more likely to help than a generic app with broad claims. Success also depends on whether the content is evidence-based, easy to use, and relevant to the patient’s language, goals, and daily life.

Patient engagement matters greatly. People who open the program consistently, complete sessions, respond to prompts, and apply what they learn are more likely to benefit. Support from a clinician can improve this process by setting goals, reviewing progress, and helping solve problems. In some cases, digital tools work especially well when paired with in-person care, such as psychiatry treatment or ongoing coaching for lifestyle-related conditions.

Other practical issues can also affect results. These include digital literacy, comfort with technology, internet access, privacy concerns, and the presence of symptoms that make concentration difficult. A digital therapeutic may be less suitable for someone with severe cognitive impairment, a crisis-level psychiatric condition, or a medical problem that needs physical examination and urgent treatment rather than remote self-guided support.

Safety, limitations, and how doctors evaluate them

Digital therapeutics can be helpful, but they also have limitations. They may not provide the nuance of a face-to-face assessment, and they cannot physically examine a patient. They are not appropriate for emergencies such as chest pain, stroke symptoms, suicidal crisis, severe shortness of breath, or sudden neurological changes. In those situations, immediate medical care is essential.

Doctors often look at several questions before recommending a digital therapeutic. They consider whether the tool is intended for a specific condition, whether it has supporting clinical evidence, how patient data are handled, and whether the program fits into the person’s overall treatment plan. They also review whether a patient is likely to use it consistently and whether there are barriers such as language, accessibility, or symptoms that require closer in-person monitoring.

Another limitation is that not all health apps are true digital therapeutics. Some offer useful education or tracking features but are not designed or tested as treatments. Patients may wish to ask whether a product has been studied, what outcome it is meant to improve, and how progress should be measured. This can help separate realistic clinical tools from overly broad promises.

How to decide if digital therapeutics are right for a patient

A practical way to decide is to start with the health goal. Is the person trying to improve sleep, build healthier habits, manage a chronic condition, reduce anxiety symptoms, or stay more consistent with a treatment plan? Once the goal is clear, a clinician can help identify whether a digital therapeutic exists for that purpose and whether it should be used alone or as an add-on to standard care.

It can also help to ask simple questions before starting: What problem is this tool designed to address? How often should it be used? How long does it usually take to see improvement? What signs suggest it is helping, and what signs mean the plan should change? This type of discussion helps set realistic expectations and prevents disappointment from expecting too much, too soon.

Near the end of the decision process, patients may also want to discuss follow-up. Reviewing symptoms, function, and adherence after a few weeks can show whether the tool is useful enough to continue. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat many conditions that may involve digital care support, including areas such as pulmonology treatment and chronic disease management for international patients.

When to seek medical advice

A doctor should be consulted before relying on a digital therapeutic for a new diagnosis, persistent symptoms, or a condition that is not well controlled. Professional assessment is especially important when symptoms interfere with daily life, sleep, mood, breathing, movement, or safety. A clinician can confirm the diagnosis, rule out other causes, and explain whether digital support is appropriate.

Urgent care is needed for severe or sudden symptoms, including thoughts of self-harm, chest pain, signs of stroke, fainting, severe breathing difficulty, or sudden weakness. Digital tools should never delay emergency evaluation. Even in non-urgent situations, follow-up matters if symptoms are getting worse, not improving, or becoming more complicated.

In many cases, the most effective approach combines digital support with conventional care. That may include doctor visits, laboratory tests, counseling, rehabilitation, or medication when needed. The main aim is not to replace medical care, but to strengthen it with practical, evidence-based support between appointments.

Frequently asked questions

Are digital therapeutics the same as health or fitness apps?

No. Digital therapeutics are designed to achieve a specific medical or behavioral outcome and are typically supported by clinical evidence. General wellness apps may still be useful, but they are not always tested or intended to function as treatment.

Can digital therapeutics replace a doctor or medication?

Usually not. They are most often used to complement standard medical care, not replace diagnosis, monitoring, or treatment when those are needed. Some people may use them as part of a broader plan that still includes clinician follow-up and, when appropriate, medication.

How long does it take to see results from digital therapeutics?

It depends on the condition, the program, and how consistently it is used. Some people notice small improvements within a few weeks, while others need longer to see meaningful changes. Progress is often gradual and linked to regular engagement.

Who is not a good candidate for digital therapeutics?

They may be less suitable for people in medical or psychiatric crisis, those with symptoms needing urgent in-person assessment, or those unable to use the technology reliably. They may also be a poor fit if the condition is too complex for self-guided support alone.

Are prescription digital therapeutics different from nonprescription ones?

Yes. Prescription digital therapeutics are typically intended for specific clinical use under professional guidance and may have more formal oversight depending on the healthcare system. Nonprescription tools may still be helpful, but they vary more widely in quality, evidence, and intended use.

What should a patient ask before starting a digital therapeutic?

Helpful questions include what condition the tool is for, what evidence supports it, how often it should be used, and how success will be measured. It is also wise to ask about privacy, follow-up, and what symptoms would mean in-person medical care is needed.

References

• World Health Organization
• U.S. Food and Drug Administration
• National Institute for Health and Care Excellence
• National Institutes of Health
• American Medical Association

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.